Comparison of Two Screening Strategies for Gestational Diabetes (GDM2)

Completed · Not applicable

Conditions studied: Gestational Diabetes, Pregnancy, Glucose Intolerance

In brief

This is a single site blinded RCT of 920 pregnant women with singleton gestation designed to compare the Carpenter-Coustan and IADPSG criteria for diagnosing gestational diabetes. Maternal metabolic profiles and infant growth will be assessed at randomization and at one year postpartum.

Key facts

Study ID

NCT02309138

Run by

Esa M Davis, MD MPH FAAFP

People needed

921

Starts

2015-08-11

Expected to finish

2020-06-05

Last updated by the study team

2020-07-20

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Pregnancy between 18-24 weeks of gestation
• Singleton gestation
• Planning to deliver at Magee-Womens Hospital, Pittsburgh, Pennsylvania

You may not qualify if…

• Preexisting type 1 or 2 diabetes
• Diabetes diagnosed at less than 24 weeks gestational age (GA)
• Multiple gestations ( e.g. twins or triplets)
• Hypertension requiring medications
• Corticosteroid (IM, oral or IV) use in the 30 days prior to enrollment
• Major congenital anomaly with anticipated preterm delivery due to maternal or fetal indications < 28 wks GA
• Inability to complete the glucose testing before 30 completed weeks GA
• Advanced HIV( on medications that cause hyperglycemia), severe liver disease, gastric bypass surgery or other illness/surgeries that preclude them from drinking the glucola solution.

Where it is running

• UPMC- Magee Womens Hospital — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.